mProX™ Human CACNA1B Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Ion Channel Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
There are currently no Customer reviews or questions for mProX™ Human CACNA1B Stable Cell Line (S01YF-1123-KX12). Click the button above to contact us or submit your feedback about this product.
Shirley (Verified Customer)
Sherry Smith (Creative Biolabs Scientific Support)
Linda (Verified Customer)
Sherry Smith (Creative Biolabs Scientific Support)
Published Data
Fig.1 e37a-Cacna1b splice isoforms are expressed in mPFC, vHPC and AMY.
An agarose gel electrophoresis of the undigested PCR products of the RT samples from mPFC, vHPC, and AMY is shown in the representative image. Every RNA sample had negative controls that lacked reverse transcriptase.
Ref: Bunda, Alexandra, et al. "Cacna1b alternative splicing impacts excitatory neurotransmission and is linked to behavioral responses to aversive stimuli." Molecular brain 12.1 (2019): 1-14.
Pubmed: 31630675
DOI: 10.1186/s13041-019-0500-1
Research Highlights
A gain-of-function contributing to the observed hyperexcitability feature of this distinct myoclonus-dystonia-like disease linked to cardiac arrhythmias could be explained by functional alterations.
Groen, Justus L., et al. "CACNA1B mutation is linked to unique myoclonus-dystonia syndrome." Human molecular genetics 24.4 (2015): 987-993.
Pubmed:
25296916
DOI:
10.1093/hmg/ddu513
The primary goal of this study was to investigate the role that Calcium Voltage-Gated Channel Subunit Alpha1 B (CACNA1B) plays in the development of breast cancer and the associated system.
Jin, Yong-Mei, et al. "CACNA1B facilitates breast cancer cell growth and migration by regulating cyclin D1 and EMT: the implication of CACNA1B in breast cancer." Journal of Receptors and Signal Transduction 42.1 (2022): 1-8.
Pubmed:
33100116
DOI:
10.1080/10799893.2020.1837871